Overview

Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy of rituximab, gemcitabine, oxaliplatin and dexametasone (R-GemOx) chemotherapy schedule.
Phase:
Phase 2
Details
Lead Sponsor:
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Treatments:
Gemcitabine
Oxaliplatin
Rituximab